Navigation Links
Key Stakeholders to Discuss Regulatory Issues Related to the Use of Study Endpoints in Multinational Clinical Trials
Date:9/2/2009

The Drug Information Association (DIA) Study Endpoints Special Interest Area Community (SIAC) will host Measuring Study Endpoints in Multinational Clinical Trials: Outcomes Reported from the Viewpoint of the Clinician, Patient, and Caregiver from October 26-27, 2009 in New Orleans, LA.

Horsham, PA (Vocus) September 2, 2009 --The Drug Information Association (DIA) Study Endpoints Special Interest Area Community (SIAC) will host Measuring Study Endpoints in Multinational Clinical Trials: Outcomes Reported from the Viewpoint of the Clinician, Patient, and Caregiver from October 26-27, 2009 in New Orleans, LA.

Representatives from industry, FDA, and EMEA will convene to discuss the scientific and regulatory issues surrounding the use of study endpoints in support of medical product labeling claims. Sessions will discuss common principles for the development and validation of all study endpoint measures and the relationships between entry criteria and outcome measurement and between different types of endpoint measures. Specific sessions include:

 
  • Defining Terms and Setting the Regulatory Context
  • Models, Measures and Claims   
  • Evaluating and Demonstrating Content Validity
  • Regulatory Perspective of Content Validity in Pediatric, Caregiver, and Clinician-Reported Outcomes
  • Practical Considerations for Multinational Clinical Trials Defining a Research Agenda for Study Endpoint Measurement and Multinational Clinical Trials
"There has been significant discussion, but little consensus with respect to a common set of best practices applicable across all types of study endpoints in clinical trials," says Laurie Burke, MPH, Capt. USPHS, Director, Study Endpoints and Labeling, Office of New Drugs, CDER, FDA. "This conference brings together key stakeholders to discuss the conceptual, measurement, and practical issues regarding study endpoints when applied to product development."

Click here to register.

About the Drug Information Association (DIA):
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
+1-215-293-5812

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2822344.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. ABMS and NQF Convene Summit on Enhancing Physician Performance: Stakeholders Agree Board Certification Should Play Bigger Role in Healthcare Quality Improvement
2. Patient-Centered Primary Care Collaborative Stakeholders Come to Washington, DC for July Working Meeting
3. Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare
4. HIMSS Electronic Health Record Association Reaches Out to Key Stakeholders on Meaningful Use of Certified EHRs
5. Major Stakeholders in Health Reform Debate Call for Greater Focus on Disease Prevention and Management in Senate Finance Committees Policy Options Paper
6. Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals
7. Patient-Centered Primary Care Collaborative Stakeholders Convene in Washington, DC for Working Meeting
8. Stakeholders and public should use 20 specific health indicators
9. Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications
10. Newly Formed Consortium to Combat Medical Fraud Announces National Agenda to Intensify Fight Against Health Care Fraud Goals: Collaboration Across Industries; Alignment of Resources; Increased Awareness Among Public and Private Stakeholders Including Fede
11. ADA Calls for All Stakeholders to Work Together to Help Medicaid
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Key Stakeholders to Discuss Regulatory Issues Related to the Use of Study Endpoints in Multinational Clinical Trials 
(Date:3/24/2017)... ... 2017 , ... “The Communion of Saints: A Pastor’s Potpourri ... congregations across the United States. “The Communion of Saints” is the creation ... served congregations in seven states throughout his long career of devotion to the ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health Organization declared ... be four million Zika-related cases in the Americas within the next year. Lyme disease ... reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The physicians ... location in the greater Houston Area. The new location is located at 2255 E. ... Hospital in Springwoods Village. This newest location will provide patients living in the north ...
(Date:3/23/2017)... ... ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the opening ... is the group’s second in New Braunfels and 22nd in Texas. , TexPTS co-founder ... brings things full circle for the group, “It’s crazy to think that we opened ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The IoT (Internet ... WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... the IoT will have a value anywhere from $4 trillion to $11 trillion dollars ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017  GenomeDx Biosciences today ... Information Database) and Decipher® Prostate Cancer Classifier tests will ... Association of Urology (EAU) Congress held March 24 to ... The Annual EAU Congress is Europe,s ... comprehensive research in the urological field. The ...
(Date:3/24/2017)... , March 23, 2017  HealthMine surveys with ... 2017 revealed that health plan members want help from ... to stay engaged in their health, 2) help closing ... integrated platform for health and 5) relevant, real-time guidance. ... and lowering healthcare costs. A ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology: